The Evolving Treatment Landscape of FLT3-Mutated Acute Myeloid Leukemia (AML)

Join the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, as they dive deep into the complexities of FLT3-positive acute myeloid leukemia (AML) in this insightful podcast episode. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9... Apple Podcast: https://podcasts.apple.com/us/podcast... Follow us on social media: •⁠ ⁠X/Twitter: https://x.com/oncbrothers •⁠ ⁠Instagram:   / oncbrothers   •⁠ Website: https://oncbrothers.com/ Featuring expert leukemia specialists Uma Borate, MD; Naval Daver, MD; and Nicholas Short, MD, the discussion covers essential topics including: • The prevalence and significance of FLT3 mutations in AML • Current testing protocols and the importance of retesting during disease progression • Treatment options, including induction chemotherapy, FLT3 inhibitors, and the role of transplantation • The evolving prognostic landscape of FLT3 mutations and their implications for patient outcomes • Insights into the latest clinical trials and emerging therapies, including combinations with hypomethylating agents (HMAs) and venetoclax • Management of side effects and the importance of patient education Whether you're a healthcare professional or someone interested in the latest advancements in leukemia treatment, this episode provides valuable insights into the management of FLT3-positive AML. Tune in for a comprehensive understanding of this critical topic in oncology! Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers! #FLT3positive, #AcuteMyeloidLeukemia, #FLT3inhibitor, #HMA, #OncologyBrothers